Breaking News Instant updates and real-time market news.

BAC

Bank of America

$28.78

0.095 (0.33%)

, GILD

Gilead

$77.61

1.73 (2.28%)

08:55
07/13/18
07/13
08:55
07/13/18
08:55

Notable open interest changes for July 13th

Thursday's total option volume of 17.0 million contracts resulted in net open interest growth of 2.50 million calls and 2.37 million puts. Bank of America (BAC), Gilead (GILD), Broadcom (AVGO) and MGM Resorts (MGM) saw the greatest growth. Top five new positions opened include 30k PagSeguro Digital (PAGS) Nov-18 25 calls, 30k Bank of America (BAC) 8/3 weekly 30.5 calls, 20k Gilead (GILD) Aug-18 75 puts, 20k Gilead (GILD) Jul-18 75 puts and 20k D R Horton (DHI) 7/27 weekly 42.5 calls.

BAC

Bank of America

$28.78

0.095 (0.33%)

GILD

Gilead

$77.61

1.73 (2.28%)

AVGO

Broadcom

$209.91

-19.84 (-8.64%)

MGM

MGM Resorts

$30.49

0.5 (1.67%)

  • 16

    Jul

  • 02

    Aug

BAC Bank of America
$28.78

0.095 (0.33%)

07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
GILD Gilead
$77.61

1.73 (2.28%)

07/02/18
ROTH
07/02/18
NO CHANGE
Target $22
ROTH
Buy
Cryoport price target raised to $22 from $12.50 at Roth Capital
Roth Capital analyst Richard Baldry raised his price target for Cryoport (CYRX) to $22 from $12.50 while reiterating a Buy rating on the shares. The analyst notes that the European Medicines Agency recommended "marketing authorizations" for therapies developed by two of Cryoport's clients, Gilead's (GILD) Yescarta and Novartis' (NVS) Kymriah. Baldry believes these two approvals roughly double the addressable market for the therapies and offer upside potential to our 2019 forecasts.
06/28/18
06/28/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CBS (CBS) initiated with an Outperform at Imperial Capital. 2. Limoneira (LMNR) initiated with a Buy at Stifel. 3. Keryx (KERX) initiated with a Buy at H.C. Wainwright. 4. Zosano Pharma (ZSAN) initiated with a Buy at BTIG. 5. Gilead (GILD) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/29/18
WBLR
06/29/18
NO CHANGE
WBLR
Outperform
Cambrex risk/reward compelling for patient investors, says William Blair
Shares of Cambrex (CBM) are down roughly 5% since reporting softer Q1 results in early May, William Blair analyst John Kreger tells investors in a research note. The analyst expects a stronger Q2 relative to Q1, which he believes should keep the full-year outlook on track. Further, his sum-of-the-parts analysis indicates that Cambrex is reasonably valued even if the Gilead (GILD) business continues to decline quickly. Kreger calculates Cambrex's base business, excluding hepatitis C revenues from Gilead, is currently valued at 11.3 times his 2019 EBITDA estimate. This is a "meaningful" discount to both its public and private peers, which have garnered deal multiples in the 13-14 times range, the analyst points out. He believes the stock's risk/reward profile is "compelling for investors willing to be patient." Kreger reiterates an Outperform rating on Cambrex.
06/29/18
ROTH
06/29/18
NO CHANGE
Target $22
ROTH
Buy
Cryoport price target raised to $22 from $12.50 at Roth Capital
Roth Capital analyst Richard Baldry reiterated a Buy rating on Cryoport (CYRX) and raised his price target to $22 from $12.50 after the EMA this morning recommended "marketing authorizations" for Gilead's (GILD) Yescarta and Novartis' (NVS) Kymriah, therapies developed by two of Cryoport's clients. In a research note to investors, Baldry said he believes the two approvals roughly double the addressable market for the therapies and offer upside potential to 2019 forecasts and sees further commercial approvals as likely.
AVGO Broadcom
$209.91

-19.84 (-8.64%)

07/12/18
RHCO
07/12/18
NO CHANGE
Target $63
RHCO
Buy
CA Technologies buyout could be positive for Okta, says SunTrust
SunTrust analyst Terry Tillman said Broadcom's (AVGO) acquisition of CA Technologies (CA) could present a potential disruption of the business and lead to incremental share gains by Okta (OKTA) in the multiple segments of identity and access management markets where the two compete. The distractions that come from a large buyout like this could drive share gains and billings activity for Okta "relatively quickly," Tillman tells investors. He reiterates a Buy rating and $63 price target on Okta shares.
07/13/18
BMOC
07/13/18
DOWNGRADE
BMOC
Market Perform
Broadcom downgraded to Market Perform from Outperform at BMO Capital
07/13/18
BMOC
07/13/18
DOWNGRADE
Target $230
BMOC
Market Perform
Broadcom downgraded to Market Perform at BMO Capital after CA acquisition
As reported earlier, BMO Capital analyst Ambrish Srivastava downgraded Broadcom (AVGO) to Market Perform from Outperform and slashed his price target to $230 from $345. The analyst points to its decision to acquire CA Technologies (CA), a company with half of its business in decline, being "so far out of the company's core competency and inconsistent with the company's recent messaging, that it raises more questions than answers". Srivastava adds that while Broadcom has a decent history of "acquiring underperforming semi assets, aggressively cutting costs, and integrating the acquisitions", he says it would be "presumptuous" to expect a repeat of that pattern in software given CA's declining mainframe business.
07/13/18
07/13/18
DOWNGRADE

Market Perform
Broadcom downgraded to Market Perform on strategy change at Raymond James
As previously reported, Raymond James downgraded Broadcom (AVGO) to Market Perform from Strong Buy. Analyst Chris Caso said Broadcom's acquisition of CA Technologies (CA) signals the company is taking a different path towards strategy than what the company led investors to expect a year ago. Caso said the company's revised strategy seeks to consolidate a broader areas of technology, pursuing slower growth, high cash flow businesses, rather than returning cash to shareholders and pursuing smaller deals after successfully consolidating the networking semiconductor industry. Broadcom's new strategy carries increased risks, and will pressure Broadcom's multiple, Caso wrote in a note to investors.
MGM MGM Resorts
$30.49

0.5 (1.67%)

07/11/18
JPMS
07/11/18
NO CHANGE
Target $37
JPMS
Overweight
MGM Resorts should be bought into back half of year, says JPMorgan
JPMorgan analyst Joseph Greff recommends buying shares of MGM Resorts heading into the back half of 2018. The stock offers an attractive risk/reward and setup for 2019, Greff tells investors in a research note. The analyst attributes the 10% year-to-date selloff to MGM's lowered 2018 guidance in April, an "uninspiring" investor day in May, and "disappointing" Macau market-wide gross gaming revenue growth in May and June. He believes most of the issues that have caused 2018's underperformance are transitory and that expectations are "reasonably/incredibly low." Greff lowered his price target for MGM shares to $37 from $41 and keeps an Overweight rating on the name.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
06/25/18
GSCO
06/25/18
DOWNGRADE
GSCO
Neutral
MGM Resorts downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Stephen Grambling downgraded MGM Resorts to Neutral from Buy, citing the delays experienced at Park MGM along with a slower than anticipated recovery at Mandalay Bay. The analyst also points to the new competition in Atlantic City, such as the expected open of Ocean Resort Casino later this week as well as the softer ramp at the Macau properties. Grambling notes that while he is constructive on MGM based on its positive Las Vegas backdrop, the catalysts for the stock are limited given its current valuation.
07/05/18
MSCO
07/05/18
NO CHANGE
MSCO
Pullback in Macau gaming names a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Thomas Allen believes the recent selloff in Macau gaming stocks is overdone, as he contends the fact that Macau's gaming revenue growth has missed on the headline for two months in a row is attributable to rising expectations, foreign exchange impacts and likely an improper factoring in of seasonality and the World Cup. Q2 gross gaming revenue growth of 17.2% still beat his forecast of 16%, noted Allen, who said Las Vegas Sands (LVS) continues to be his favored gaming name. He also has an Overweight rating on MGM Resorts (MGM). Allen keeps an Equal Weight rating on Wynn Resorts (WYNN), but sees the stock becoming increasingly attractive if Macau is still "very healthy," as he suspects.

TODAY'S FREE FLY STORIES

BHLB

Berkshire Hills Bancorp

$40.80

0.15 (0.37%)

22:34
07/18/18
07/18
22:34
07/18/18
22:34
Upgrade
Berkshire Hills Bancorp rating change at Compass Point »

Berkshire Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

PG

Procter & Gamble

$79.71

-0.34 (-0.42%)

22:34
07/18/18
07/18
22:34
07/18/18
22:34
Downgrade
Procter & Gamble rating change at UBS »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

GWW

Grainger

$338.99

33.78 (11.07%)

22:33
07/18/18
07/18
22:33
07/18/18
22:33
Upgrade
Grainger rating change at UBS »

Grainger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

MS

Morgan Stanley

$50.54

1.34 (2.72%)

22:32
07/18/18
07/18
22:32
07/18/18
22:32
Upgrade
Morgan Stanley rating change at Bernstein »

Morgan Stanley upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ESTA

Establishment Labs

$0.00

(0.00%)

22:17
07/18/18
07/18
22:17
07/18/18
22:17
Syndicate
Establishment Labs 3.715M share IPO priced at $18.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

CNST

Constellation Pharmaceuticals

$0.00

(0.00%)

22:12
07/18/18
07/18
22:12
07/18/18
22:12
Syndicate
Constellation Pharmaceuticals 4M share IPO priced at $15.00 »

The deal size was reduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

CARB

Carbonite

$37.90

0.6 (1.61%)

22:09
07/18/18
07/18
22:09
07/18/18
22:09
Syndicate
Carbonite 5.463M share Secondary priced at $37.50 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Aug

  • 16

    Aug

  • 19

    Jul

TLRY

Tilray

$0.00

(0.00%)

22:04
07/18/18
07/18
22:04
07/18/18
22:04
Syndicate
Tilray 9M share IPO priced at $17.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

JBLU

JetBlue

$19.97

0.44 (2.25%)

, EADSY

Airbus

$0.00

(0.00%)

20:47
07/18/18
07/18
20:47
07/18/18
20:47
Periodicals
JetBlue founder to launch new U.S. low-cost airline, LA Times says »

JetBlue (JBLU) founder…

JBLU

JetBlue

$19.97

0.44 (2.25%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

PTC

PTC

$98.51

-0.4 (-0.40%)

20:28
07/18/18
07/18
20:28
07/18/18
20:28
Recommendations
PTC analyst commentary at MUFG »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PM

Philip Morris

$82.16

-0.17 (-0.21%)

, UNP

Union Pacific

$141.26

2.96 (2.14%)

20:25
07/18/18
07/18
20:25
07/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$82.16

-0.17 (-0.21%)

UNP

Union Pacific

$141.26

2.96 (2.14%)

DHR

Danaher

$98.80

-0.78 (-0.78%)

BK

BNY Mellon

$55.64

1.59 (2.94%)

BX

Blackstone

$36.23

0.52 (1.46%)

BBT

BB&T

$52.99

1 (1.92%)

TRV

Travelers

$130.03

1.26 (0.98%)

PPG

PPG

$106.84

1.43 (1.36%)

KEY

KeyCorp

$20.30

0.24 (1.20%)

FITB

Fifth Third

$30.26

0.75 (2.54%)

NUE

Nucor

$65.65

1.045 (1.62%)

GPC

Genuine Parts

$94.64

0.47 (0.50%)

ADS

Alliance Data

$226.51

1.13 (0.50%)

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

DOV

Dover

$74.21

-0.37 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 08

    Aug

  • 26

    Aug

  • 21

    Sep

  • 05

    Oct

  • 30

    Oct

FFKT

Farmers Capital Bank

$53.50

0.65 (1.23%)

20:23
07/18/18
07/18
20:23
07/18/18
20:23
Earnings
Farmers Capital Bank reports Q2 EPS 83c, consensus 73c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$71.49

0.06 (0.08%)

20:13
07/18/18
07/18
20:13
07/18/18
20:13
Recommendations
Anadarko analyst commentary at MUFG »

Anadarko price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

HES

Hess Corp.

$64.14

0.67 (1.06%)

20:00
07/18/18
07/18
20:00
07/18/18
20:00
Recommendations
Hess Corp. analyst commentary at MUFG »

Hess Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NBL

Noble Energy

$34.34

-0.11 (-0.32%)

19:52
07/18/18
07/18
19:52
07/18/18
19:52
Recommendations
Noble Energy analyst commentary at MUFG »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

NDLS

Noodles & Company

$11.80

-0.35 (-2.88%)

, IBM

IBM

$144.44

0.98 (0.68%)

19:08
07/18/18
07/18
19:08
07/18/18
19:08
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

NDLS

Noodles & Company

$11.80

-0.35 (-2.88%)

IBM

IBM

$144.44

0.98 (0.68%)

BHLB

Berkshire Hills Bancorp

$40.80

0.15 (0.37%)

CL

Colgate-Palmolive

$64.81

-0.76 (-1.16%)

EGAN

eGain

$13.15

-0.75 (-5.40%)

EBAY

eBay

$37.95

0.13 (0.34%)

CCK

Crown Holdings

$45.12

-0.265 (-0.58%)

PTC

PTC

$98.51

-0.4 (-0.40%)

AXP

American Express

$102.98

1.84 (1.82%)

URI

United Rentals

$155.14

2.94 (1.93%)

AA

Alcoa

$47.90

-0.105 (-0.22%)

SPWH

Sportsman's Warehouse

$5.23

-0.16 (-2.97%)

RUN

Sunrun

$15.16

-0.02 (-0.13%)

CLX

Clorox

$129.50

-5.5 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 02

    Aug

  • 06

    Aug

  • 08

    Aug

  • 09

    Aug

  • 19

    Jul

GSBC

Great Southern Bancorp

$58.55

-0.2 (-0.34%)

19:03
07/18/18
07/18
19:03
07/18/18
19:03
Earnings
Great Southern Bancorp reports Q2 EPS 97c, consensus 94c »

Reports Q2 NII $41.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$45.82

-0.48 (-1.04%)

18:40
07/18/18
07/18
18:40
07/18/18
18:40
Hot Stocks
OMA Airports reports Q2 passenger traffic up 9.6% »

OMA generated a 25.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTN

Optinose

$26.97

0.36 (1.35%)

18:35
07/18/18
07/18
18:35
07/18/18
18:35
Recommendations
Optinose analyst commentary at BMO Capital »

Optinose's Xhance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$31.73

-0.02 (-0.06%)

18:29
07/18/18
07/18
18:29
07/18/18
18:29
Periodicals
DOJ: AT&T-Time Warner ruling ignored 'basic economics,' FT reports »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

, TRCO

Tribune Media

$34.09

0.79 (2.37%)

18:26
07/18/18
07/18
18:26
07/18/18
18:26
Hot Stocks
FCC votes unanimously to adopt hearing order on Sinclair-Tribune deal »

This evening, the Federal…

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

TRCO

Tribune Media

$34.09

0.79 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

RUN

Sunrun

$15.16

-0.02 (-0.13%)

, JKS

JinkoSolar

$13.70

-0.1 (-0.72%)

18:25
07/18/18
07/18
18:25
07/18/18
18:25
Downgrade
Sunrun, JinkoSolar, Canadian Solar, Vivint Solar rating change at Goldman Sachs »

Sunrun downgraded to…

RUN

Sunrun

$15.16

-0.02 (-0.13%)

JKS

JinkoSolar

$13.70

-0.1 (-0.72%)

CSIQ

Canadian Solar

$12.83

0.15 (1.18%)

VSLR

Vivint Solar

$5.20

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

, TRCO

Tribune Media

$34.09

0.79 (2.37%)

18:25
07/18/18
07/18
18:25
07/18/18
18:25
Periodicals
Breaking Periodicals news story on Sinclair Broadcast, Tribune Media »

FCC votes unanimously to…

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

TRCO

Tribune Media

$34.09

0.79 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

RUN

Sunrun

$15.16

-0.02 (-0.13%)

18:13
07/18/18
07/18
18:13
07/18/18
18:13
Downgrade
Sunrun rating change at Goldman Sachs »

Sunrun downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

UNH

UnitedHealth

$255.43

5.11 (2.04%)

, THC

Tenet

$34.57

-0.37 (-1.06%)

18:09
07/18/18
07/18
18:09
07/18/18
18:09
Periodicals
UnitedHealth among suitors eyeing Tenet's Conifer unit, WSJ reports »

UnitedHealth (UNH) is…

UNH

UnitedHealth

$255.43

5.11 (2.04%)

THC

Tenet

$34.57

-0.37 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.